The global venous ulcer treatment market, valued at USD 2.96 billion in 2023, is projected to experience robust growth, with a compound annual growth rate (CAGR) of 6.5% from 2023 to 2033. By the end of the forecast period, the market is expected to reach USD 7.61 billion, driven by key trends such as increasing prevalence of venous ulcers and advances in treatment options.
Venous ulcers are the most common form of leg ulcers, accounting for more than 90% of all cases, according to the National Health Service (NHS). These chronic wounds affect approximately 1 in 500 people in the UK, and the prevalence is rising globally, further fueling the demand for effective treatment solutions.
The market’s growth is primarily attributed to the rising incidence of venous ulcers and the increasing adoption of compression therapy, a highly effective treatment modality for venous leg ulcers. Compression therapy has shown significant promise in promoting healing and preventing recurrence, making it a cornerstone of treatment.
Additionally, growing awareness about available therapeutic interventions and ongoing advancements in treatment methodologies are expected to further accelerate market growth. Innovations in wound care technology and the development of new drug formulations and medical devices are enhancing the management of venous ulcers, contributing to the expansion of the market.
The increasing availability of innovative treatments, coupled with an aging population prone to conditions such as venous insufficiency, is expected to further drive the growth of the venous ulcer treatment market in the coming years.
Key Takeaways from the Market Study:
- Demand increased significantly from 2018 to 2022, with a CAGR of 5.8%.
- According to a National Library of Medicine report, the overall prevalence of this disease is 1%, rising to 3% among those over 65.
- The prevalence of venous ulcers in the United States ranges from 1% to 3%. 2,3 According to the AAFP organization
- The global venous ulcer treatment market is estimated to be worth USD 7.61 billion in 2033.
“Emerging breakthroughs in treatment therapy are expected to contribute significantly to the growth of the venous ulcer treatment market in the coming years. The growing number of players involved in the development of ultra-sophisticated products for the management of venous ulcers is expected to meet the growing demand for a robust solution for venous ulcers,” says the FMI analyst.
Enhanced Market Demand! Discover Thorough Trends and Insights in Our Complete Report!
Key Market Players:
Significant players in the Venous Ulcer Treatment market are Angiodynamics, Sigvaris Global, Medi GmbH & Co. KG, Activa Healthcare, 3M, Medtronic, Bristol Myers Squibb Co, Sanofi, Bayer AG, Pfizer Inc, Novo Nordisk A/S. Some of the latest developments are:
- The Sigvaris ULCER X Wound Healing Compression Stocking Kit, which was introduced in September 2020, is a simple and advanced solution for effectively treating venous conditions and intense leg ulceration.
- Medi GmbH & Co. KG introduced circaid® for venous leg ulcers as an adjustable compression device for the therapies of venous leg ulcers in February 2020.
Key Segments Profiled in the Venous Ulcer Treatment Market Industry Survey:
By Diseases Type:
- Arterial Ulcers
- Neurotropic Ulcer
- Venous Ulcers
- Diabetic Ulcers
By Treatment Type:
- Compression Therapy
- Surgical Therapy
- Skin Grafting
- Advanced Wound Dressing
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- South Asia
- East Asia
- Latin America
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
